“Cost-Effectiveness Analysis of Peginterferon Beta-1a in the Treatment of Relapsing-Remitting Multiple Sclerosis in Italy: Results of an Updated Analysis” (2018) Farmeconomia. Health economics and therapeutic pathways, 19(1). doi:10.7175/fe.v19i1.1385.